SOLIFENACIN SUCCINATE
These highlights do not include all the information needed to use SOLIFENACIN SUCCINATE TABLETS safely and effectively. See full prescribing information for SOLIFENACIN SUCCINATE TABLETS. SOLIFENACIN SUCCINATE tablets, for oral use Initial U.S. Approval: 2004
db6c24ae-e44b-456c-8e73-5961313ccf08
HUMAN PRESCRIPTION DRUG LABEL
Feb 9, 2022
Graviti Pharmaceuticals Private Limited
DUNS: 650884781
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
SOLIFENACIN SUCCINATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (10)
SOLIFENACIN SUCCINATE
Product Details
FDA regulatory identification and product classification information